Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-08-20
2008-03-11
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S268000, C544S269000, C544S270000, C544S118000, C544S310000, C540S575000, C514S263200, C514S263210, C514S263220, C514S234200
Reexamination Certificate
active
07342006
ABSTRACT:
Selective antagonists of A2Badenosine receptors like those of formula I are provide.The compounds and compositions are useful as pharmaceutical agents.
REFERENCES:
patent: 6770267 (2004-08-01), Daluge et al.
patent: 2007/0219221 (2007-09-01), Zeng et al.
patent: WO 03/042214 (2003-05-01), None
patent: WO 03/063800 (2003-08-01), None
Sekine et al., Chemical and pharmaceutical bulletin 1989, vol. 37, No. 8, pp. 1987-1989.
Scammells, Journal of Medicinal Chemistry (1994), 37(17), 2704-12.
Rieger Jayson M.
Thompson Robert D.
Wang Guoquan
Adenosine Therapeutics, LLC
Berch Mark L.
Hallowell Kelly
Williams Mullen
LandOfFree
Substituted 8-heteroaryl xanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 8-heteroaryl xanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 8-heteroaryl xanthines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3980667